08:58 AM EDT, 08/19/2024 (MT Newswires) -- Health care stocks were flat to higher premarket Monday, with the iShares Biotechnology ETF (IBB) unchanged and The Health Care Select Sector SPDR Fund (XLV) up 0.2%.

Liquidia ( LQDA ) shares were down more than 34% after the company said it has received tentative US Food and Drug Administration approval for its drug Yutrepia for the treatment of adults with pulmonary arterial hypertension and pulmonary hypertension associated with lung disease, but final approval will only be secured after the 2025 expiration of the exclusivity period for United Therapeutics's ( UTHR ) Tyvaso DPI.